MediciNova Shares Rise 14% After Positive Data for MN-166 Trial
By Chris Wack MediciNova shares were up 14% to $2.30 after the company reported positive data for its phase 2 clinical trial of MN-166 ibudilast in...
Source: marketwatch.com
4875 To News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from 4875 To. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In 4875 To Today - Breaking & Trending Today